Tetracycline

Chemical formula: C₂₂H₂₄N₂O₈  Molecular mass: 444.435 g/mol  PubChem compound: 54675776

Therapeutic indications

Tetracycline is indicated for:

Infections caused by Gram-positive and Gram-negative tetracycline-sensitive organisms

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Tetracycline is a bacteriostatic broad-spectrum antibiotic, active against a wide variety of Gram-positive and Gram-negative organisms.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Streptococcal infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Streptococcal infectious disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brucellosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Brucellosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Early syphilis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Early symptomatic syphilis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Syphilis of more than one year's duration

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Latent syphilis of uncertain or more than one year’s duration, cardiovascular or late benign syphilis except neurosyphilis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gonorrhea

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Gonorrhea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Uncomplicated urethral, endocervical or rectal infections caused by Chlamydia trachomatis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Chlamydia trachomatis urethritis
Infection of cervix caused by Chlamydia trachomatis
Chlamydia trachomatis infection of anus and rectum

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Moderate to severe acne

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acne and additionally not at least one of
Acne vulgaris
Rosacea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acne vulgaris

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acne vulgaris

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Severe rosacea

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Rosacea

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Non-gonococcal urethritis caused by Ureaplasma urealyticum

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Nongonococcal urethritis caused by Ureaplasma urealyticum

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute epididymo-orchitis caused by Chlamydia trachomatis or Neisseria gonorrhoea

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute inflammation of testis and epididymis and additionally at least one of
Chlamydia trachomatis
Neisseria gonorrhoeae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tetracycline is contraindicated in the following cases:

Lactation

Lactation

Chronic renal dysfunction

Chronic renal failure syndrome

Chronic hepatic dysfunction

Chronic hepatic failure

Renal impairment

Renal failure

Systemic lupus erythematosus

Systemic lupus erythematosus

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: TETRACYCLINE Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈